Intelligent Bio Solutions Inc. Cash Flow Conversion Efficiency
Intelligent Bio Solutions Inc. cash flow conversion efficiency. Based on the latest financial reports, Intelligent Bio Solutions Inc. (INBS) has a cash flow conversion efficiency ratio of -0.601x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-3.18 Million) by net assets ($5.29 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Intelligent Bio Solutions Inc. (2017–2026)
Cash flow conversion efficiency of Intelligent Bio Solutions Inc. from 2017 to 2026. This chart illustrates how Intelligent Bio Solutions Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. View current stock price of Intelligent Bio Solutions Inc. for real-time trading data and today's change.
Intelligent Bio Solutions Inc. Cash Flow Conversion Ratio Explained
Intelligent Bio Solutions Inc. cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Intelligent Bio Solutions Inc. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Intelligent Bio Solutions Inc. ranked by their cash flow conversion efficiency. Also see market cap of Intelligent Bio Solutions Inc. for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
INC S.A.
WAR:INC
|
-0.047x |
|
KNM Group Bhd
KLSE:7164
|
-0.034x |
|
Ashoka India Equity Investment Trust PLC
LSE:AIE
|
-0.013x |
|
Tenon Medical Inc
NASDAQ:TNON
|
1.582x |
|
Versus Systems Inc
NASDAQ:VS
|
-0.133x |
|
Eminence Minerals Limited
AU:EMA
|
-0.112x |
|
Tsodilo Resources Limited
V:TSD
|
-0.037x |
|
Hansa Investment Company Ltd
LSE:HANA
|
0.324x |
Annual Cash Flow Conversion Efficiency for Intelligent Bio Solutions Inc. (2017–2026)
The table below shows the annual cash flow conversion efficiency of Intelligent Bio Solutions Inc. from 2017 to 2026. Review Intelligent Bio Solutions Inc. (INBS) free cash flow to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2026-06-30 | $5.29 Million | $-11.93 Million | -2.254x | +34.45% |
| 2025-06-30 | $2.81 Million | $-9.68 Million | -3.439x | -194.03% |
| 2024-06-30 | $8.18 Million | $-9.57 Million | -1.170x | +41.54% |
| 2023-06-30 | $3.69 Million | $-7.38 Million | -2.001x | -290.04% |
| 2022-06-30 | $6.55 Million | $-3.36 Million | -0.513x | +31.85% |
| 2021-06-30 | $15.01 Million | $-11.30 Million | -0.753x | -887.29% |
| 2020-06-30 | $-5.21 Million | $-498.62K | 0.096x | -93.18% |
| 2019-06-30 | $-3.98 Million | $-5.58 Million | 1.402x | -20.21% |
| 2018-06-30 | $-3.06 Million | $-5.38 Million | 1.758x | +4160.83% |
| 2017-06-30 | $-5.91 Million | $-243.89K | 0.041x | -- |
About Intelligent Bio Solutions Inc.
Intelligent Bio Solutions Inc., a medical technology company, focused on developing and delivering non-invasive testing, and screening solutions in Asia Pacific, the United States, the United Kingdom, and internationally. The company operates intelligent fingerprinting drug screening system, a platform to analyze fingerprint sweat analysis to detect drugs abuse; and biosensor platform. The compan… Read more